Aptorum Group Limited [NASDAQ: APM] gained 19.48% or 0.68 points to close at $4.17 with a heavy trading volume of 1581214 shares. The company report on January 20, 2021 that Aptorum Group Receives Clearance from Health Canada to Initiate a Phase 1 Clinical Trial for ALS-4, a Small Molecule Drug for Infections Caused by Staphylococcus aureus including Methicillin-resistant Staphylococcus aureus (MRSA).
Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ) (“Aptorum Group” or “Aptorum”), a biopharmaceutical company focused on novel technologies including the targeting of infectious diseases, announced that the company, through its wholly owned subsidiary, Aptorum International Limited, has received clearance from the Public Health Agency of Canada (Health Canada) regarding the Clinical Trial Application (CTA) to commence a Phase 1 study of ALS-4, an orally administered small molecule drug intended to treat infections caused by Staphylococcus aureus including MRSA.
Dr. Clark Cheng, Chief Medical Officer and Executive Director of Aptorum Group, commented, “The clearance of our CTA application for ALS-4 drug represents a significant milestone for the company and one of a number of targeted strategic goals for 2021. This milestone supports the transition of Aptorum Group to a clinical-stage company and reflects the potential of our scientific rigor and novel approach of our products. We are dedicated to delivering novel therapeutics in the field of growing unmet medical needs of infections starting with Staphylococcus aureus.”.
It opened the trading session at $3.62, the shares rose to $4.2399 and dropped to $3.60, the range by which the price of stock traded the whole day. The daily chart for APM points out that the company has recorded 24.85% gains over the past six months. However, it is still -259.48% lower than its most recent low trading price.
If we look at the average trading volume of 632.75K shares, APM reached to a volume of 1581214 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Aptorum Group Limited [APM]:
The Average True Range (ATR) for Aptorum Group Limited is set at 0.34, with the Price to Sales ratio for APM stock in the period of the last 12 months amounting to 239.22. The Price to Book ratio for the last quarter was 6.32, with the Price to Cash per share for the same quarter was set at 0.12.
Trading performance analysis for APM stock
Aptorum Group Limited [APM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 15.51. With this latest performance, APM shares gained by 25.98% in over the last four-week period, additionally plugging by 24.85% over the last 6 months – not to mention a drop of -73.03% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for APM stock in for the last two-week period is set at 70.86, with the RSI for the last a single of trading hit 75.76, and the three-weeks RSI is set at 67.78 for Aptorum Group Limited [APM]. The present Moving Average for the last 50 days of trading for this stock 3.00, while it was recorded at 3.60 for the last single week of trading, and 2.92 for the last 200 days.
Aptorum Group Limited [APM]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Aptorum Group Limited [APM] shares currently have an operating margin of -3400.52 and a Gross Margin at -291.31. Aptorum Group Limited’s Net Margin is presently recorded at -3491.77.
Return on Total Capital for APM is now -56.48, given the latest momentum, and Return on Invested Capital for the company is -66.68. Return on Equity for this stock declined to -75.54, with Return on Assets sitting at -54.14. When it comes to the capital structure of this company, Aptorum Group Limited [APM] has a Total Debt to Total Equity ratio set at 39.83. Additionally, APM Total Debt to Total Capital is recorded at 28.48, with Total Debt to Total Assets ending up at 27.20. Long-Term Debt to Equity for the company is recorded at 39.29, with the Long-Term Debt to Total Capital now at 28.10.
Reflecting on the efficiency of the workforce at the company, Aptorum Group Limited [APM] managed to generate an average of -$505,048 per employee. Receivables Turnover for the company is 0.79 with a Total Asset Turnover recorded at a value of 0.02.Aptorum Group Limited’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.00 and a Current Ratio set at 2.00.
An analysis of insider ownership at Aptorum Group Limited [APM]
There are presently around $1 million, or 0.90% of APM stock, in the hands of institutional investors. The top three institutional holders of APM stocks are: SCHONFELD STRATEGIC ADVISORS LLC with ownership of 45,100, which is approximately New of the company’s market cap and around 26.43% of the total institutional ownership; MORGAN STANLEY, holding 32,400 shares of the stock with an approximate value of $0.11 million in APM stocks shares; and GOLDMAN SACHS GROUP INC, currently with $82000.0 in APM stock with ownership of nearly New of the company’s market capitalization.
7 institutional holders increased their position in Aptorum Group Limited [NASDAQ:APM] by around 135,794 shares. Additionally, 3 investors decreased positions by around 75,918 shares, while 0 investors held positions by with 64,712 shares. The mentioned changes placed institutional holdings at 147,000 shares, according to the latest SEC report filing. APM stock had 4 new institutional investments in for a total of 105,516 shares, while 3 institutional investors sold positions of 75,918 shares during the same period.